메뉴 건너뛰기




Volumn 138, Issue 11, 2010, Pages 1422-1426

Hairy cell leukemia during pregnancy. Report of one case;Leucemia de células velludas en el embarazo. caso clínico

Author keywords

Hairy cell; Leukemia; Pregnancy complications; Splenectomy

Indexed keywords


EID: 79551632902     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/s0034-98872010001200012     Document Type: Article
Times cited : (2)

References (26)
  • 2
    • 0013879521 scopus 로고
    • Hairy cells in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes
    • Schrek R, Donnelly WJ. "Hairy" cells in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes. Blood 1966; 27: 199-211.
    • (1966) Blood , vol.27 , pp. 199-211
    • Schrek, R.1    Donnelly, W.J.2
  • 3
    • 30144443996 scopus 로고    scopus 로고
    • Lymphoma incidence patterns by WHO subtype in the United States. 1992-2001
    • Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States. 1992-2001. Blood 2006; 107: 265-76.
    • (2006) Blood , vol.107 , pp. 265-276
    • Morton, L.M.1    Wang, S.S.2    Devesa, S.S.3
  • 4
    • 0025371574 scopus 로고
    • Epidemiology of hairy cell leukemia in Los Angeles County
    • Bernstein L, Newton P, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 1990; 50: 3605-9.
    • (1990) Cancer Res , vol.50 , pp. 3605-3609
    • Bernstein, L.1    Newton, P.2    Ross, R.K.3
  • 5
    • 0028283642 scopus 로고
    • Managing hairy cell leukemia in pregnancy
    • Alothman A, Sparling TG. Managing hairy cell leukemia in pregnancy. Ann Intern Med 1994; 120: 1048-9.
    • (1994) Ann Intern Med , vol.120 , pp. 1048-1049
    • Alothman, A.1    Sparling, T.G.2
  • 6
    • 0026645154 scopus 로고
    • Interferon-a therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia
    • Baer MR, Ozer H, Foon KA. Interferon-a therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 1992;81:167-9.
    • (1992) Br J Haematol , vol.81 , pp. 167-169
    • Baer, M.R.1    Ozer, H.2    Foon, K.A.3
  • 7
    • 0023144002 scopus 로고
    • Hairy cell leukemia in pregnancy: A case report
    • Williams JK. Hairy cell leukemia in pregnancy: a case report. Am J Obstet Gynecol 1987; 156: 210-1.
    • (1987) Am J Obstet Gynecol , vol.156 , pp. 210-211
    • Williams, J.K.1
  • 8
    • 0037764931 scopus 로고    scopus 로고
    • Hairy cell leukemia: Biology, clinical diagnosis, unusual manifestations and associated disorders
    • Polliack A. Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. Rev Clin Exp Hematol 2002; 6: 366-88.
    • (2002) Rev Clin Exp Hematol , vol.6 , pp. 366-388
    • Polliack, A.1
  • 11
    • 33751090057 scopus 로고    scopus 로고
    • 2-CdA in the treatment of hairy cell leukemia: A review of long-term follow-up
    • Gidron A, Tallman MS. 2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up. Leuk Lymphoma 2006; 47: 2301-7.
    • (2006) Leuk Lymphoma , vol.47 , pp. 2301-2307
    • Gidron, A.1    Tallman, M.S.2
  • 12
    • 0036019235 scopus 로고    scopus 로고
    • Exposure-diseasecontinuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: Induction of lumbar hernia in the rat and species comparison for the teratogenic responses
    • Lau C, Narotsky MG, Lui D, et al. Exposure-diseasecontinuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: induction of lumbar hernia in the rat and species comparison for the teratogenic responses. Teratology 2002; 66: 6-18.
    • (2002) Teratology , vol.66 , pp. 6-18
    • Lau, C.1    Narotsky, M.G.2    Lui, D.3
  • 14
    • 0026573542 scopus 로고
    • Treatment of hairy cell leukemia
    • Saven A, Piro LD. Treatment of hairy cell leukemia. Blood 1992; 9: 1111-20.
    • (1992) Blood , vol.9 , pp. 1111-1120
    • Saven, A.1    Piro, L.D.2
  • 15
    • 0022637096 scopus 로고
    • Splenectomy for hairy cell leukemia: A clinical review of 63 patients
    • Van Norman AS, Nagorney DM, Martin JK, et al. Splenectomy for hairy cell leukemia: a clinical review of 63 patients. Cancer 1986; 57: 644-8.
    • (1986) Cancer , vol.57 , pp. 644-648
    • van Norman, A.S.1    Nagorney, D.M.2    Martin, J.K.3
  • 17
    • 0019505650 scopus 로고
    • Splenectomy in hairy cell leukemia: A retrospective multicenter analysis
    • Jansen J, Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 1981; 47: 2066-76.
    • (1981) Cancer , vol.47 , pp. 2066-2076
    • Jansen, J.1    Hermans, J.2
  • 18
    • 0026736849 scopus 로고
    • Splenectomy vs alpha interferon: A randomized study in patients with previously untreated hairy cell leukemia
    • Smalley RV, Connors J, Tuttle RL, et al. Splenectomy vs alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia. Am J Hematol 1992; 41: 13-8.
    • (1992) Am J Hematol , vol.41 , pp. 13-18
    • Smalley, R.V.1    Connors, J.2    Tuttle, R.L.3
  • 19
    • 0028929938 scopus 로고
    • Randomized comparison of pentostatin versus interferon alfa-2a inpreviously untreated patients with hairy cell leukemia: An Intergroup study
    • Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon alfa-2a inpreviously untreated patients with hairy cell leukemia: an Intergroup study. J Clin Oncol 1995; 13: 974-82.
    • (1995) J Clin Oncol , vol.13 , pp. 974-982
    • Grever, M.1    Kopecky, K.2    Foucar, M.K.3
  • 20
    • 0037247147 scopus 로고    scopus 로고
    • Interferon in the treatment of hairy cell leukemia
    • Ahmed S, Rai KR. Interferon in the treatment of hairy cell leukemia. Best Pract Res Clin Haematol 2003; 16: 69-81.
    • (2003) Best Pract Res Clin Haematol , vol.16 , pp. 69-81
    • Ahmed, S.1    Rai, K.R.2
  • 21
    • 1642442636 scopus 로고    scopus 로고
    • Safety of rituximab therapy during the first trimester of pregnancy: A case history
    • Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004; 72: 292-5.
    • (2004) Eur J Haematol , vol.72 , pp. 292-295
    • Kimby, E.1    Sverrisdottir, A.2    Elinder, G.3
  • 22
    • 33645500478 scopus 로고    scopus 로고
    • Administration of rituximab during the first trimester of pregnancy without consequences for the newborn
    • Ojeda-Uribe M, Gilliot C, Jung G, et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinat 2006; 26: 252-5.
    • (2006) J Perinat , vol.26 , pp. 252-255
    • Ojeda-Uribe, M.1    Gilliot, C.2    Jung, G.3
  • 23
    • 33749999729 scopus 로고    scopus 로고
    • The effects of rituximab treatment during pregnancy on a neonate
    • Friedrichs B, Tiemann M, Salwender H et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91: 1426-7.
    • (2006) Haematologica , vol.91 , pp. 1426-1427
    • Friedrichs, B.1    Tiemann, M.2    Salwender, H.3
  • 24
    • 34547483563 scopus 로고    scopus 로고
    • Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy
    • Robinson A, Watson W, Leslie K. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncol 2007; 8: 738-43.
    • (2007) Lancet Oncol , vol.8 , pp. 738-743
    • Robinson, A.1    Watson, W.2    Leslie, K.3
  • 25
    • 20744446908 scopus 로고    scopus 로고
    • Spontaneous splenic rupture in pregnancy after heparin treatment
    • Reches A, Almog R, Pauzner D, et al. Spontaneous splenic rupture in pregnancy after heparin treatment. BJOG. 2005; 112: 837-8.
    • (2005) BJOG , vol.112 , pp. 837-838
    • Reches, A.1    Almog, R.2    Pauzner, D.3
  • 26
    • 34249300449 scopus 로고    scopus 로고
    • Conflicting priorities in surgical intervention for cancer in pregnancy
    • Moran B, Yano H, Farquharson M. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol 2007; 8: 536-44.
    • (2007) Lancet Oncol , vol.8 , pp. 536-544
    • Moran, B.1    Yano, H.2    Farquharson, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.